Physician profile
Joy Rowland
NPI 1457590010
$1,940.09
in general payments reported to CMS, 2019-2025
14 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $301 · 2023: $640 · 2024: $356 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $324.23 | 2021-2024 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $259.49 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $209.02 | 2023-2025 | Puraply Wound Matrix, Puraply Antimicrobial |
| Averitas Pharma INC. | $151.26 | 2023 | Qutenza |
| Convatec INC. | $137.30 | 2023 | |
| Tandem Diabetes Care, INC. | $127.28 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $124.99 | 2022 | |
| Amgen INC. | $124.87 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $124.31 | 2023 | Krystexxa |
| Orthofix Medical, INC. | $111.11 | 2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.34 | 2022 | |
| Boston Scientific Corporation | $59.33 | 2022 | |
| Mimedx Group, INC. | $43.43 | 2025 | |
| Linvatec Corporation | $43.13 | 2023 | Colink Plating System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Rowland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.